AMBUJACEM Charts, Analysis and Tips

home > cement > ambujacem

Technical Analysis

Technical Strength: 7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 58.9. According to RSI analysis, ambujacem is technically strong. 9.0 AMBUJACEM RSI Chart
MACD (?) MACD: 2.09 and Signal Line: 1.61. According to MACD analysis, ambujacem is technically strong. 8.0 AMBUJACEM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, ambujacem is in a strong uptrend. Major support levels are 272.45, 268.957, 262.8112. 10.0 AMBUJACEM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, ambujacem is in a strong uptrend. Major support levels are 272.7633, 271.2178, 262.6856. 10.0 AMBUJACEM Exponential Moving Average Chart
Bollinger Bands (?) Bollinger bandwidth suggests a squeeze is happening, watch for a breakout.%b is 0.858. According to bollinger bands, ambujacem is technically strong. 7.0 AMBUJACEM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 275.8884 and 271.9. And resistance is at 288.8. 2.0 AMBUJACEM Fibonacci Retracement Chart
Average True Range (?) ATR: 5.97 NA AMBUJACEM Average True Range Chart
Average Directional Index (?) ADX is 11.9 which means AMBUJACEM is in a trading range and there is no trend. NA AMBUJACEM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 17, 2018
Open Price 275.35
High Price 278.95
Low Price 272.85
Close Price 277.15
Absolute Change -0.7
Percentage Change -0.252%
Weekly Change 0.38%
Monthly Change 2.4%
Yearly Change 29.4%
52-week high 291.5
52-week low 210.55
Corporate Actions
ExDate Purpose
August 02, 2017 INT DIV-Rs 1.60 per share
August 02, 2017 INTERIM DIVIDEND
March 16, 2017 DIV - RS 1.20 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.976
Confidence in Beta15.7%
Market Capital Rs. 42954.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 17 January 2018: Deliverable Quantity:1.56e+06 NA AMBUJACEM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 17 January 2018: Daily Volatility:0.2197 NA AMBUJACEM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 17 January 2018: PCR_OI:0.265 PCR:0.184 NA AMBUJACEM PCR Chart
Option Pain (?) 17 January 2018: Max Pain:275.0 NA AMBUJACEM Option Pain Chart
Premium (?) 17 January 2018 Premium: -0.5 Futures OI:13697500.0 NA AMBUJACEM Premium Chart
Option_MAX_OI (?) 17 January 2018: Price:277.15 Put with maximum OI:270.0 Call with maximum OI:280.0 NA AMBUJACEM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 276.65 13697500.0 1513.0 1559.0 277.15
February 22, 2018 276.6 327500.0 84.0 84.0 277.15

Announcements

December 26, 2017 ATrading WindowAmbuja Cements Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
November 10, 2017 AAnalysts/Institutional Investor Meet/Con. Call UpdatesAmbuja Cements Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 09, 2017 October 24, 2017 TResultsTo, inter alia, consider and approve the Unaudited Financial Results of the Company for the Third Quarter ended September 30, 2017 of the Corporate Financial Year ending December 31, 2017.
July 11, 2017 July 24, 2017 TResults/DividendTo consider the unaudited financial results for the Second Quarter/Half-year ended on June 30, 2017. The Board will also consider payment of interim dividend on equity shares.
See all Board Meetings

AMBUJACEM is part of...

Index Weightage
NIFTY NA
CNXMNC NA
CNXCMMDTY NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 267.6 Rs. 270.2 Rs. 273.7 Rs. 276.3 Rs. 279.8 Rs. 282.4 Rs. 285.9